Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
          
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Follow Up - Clinical trial / recent seroconversion
Nov 25, 2005

Following up on my first post regarding a study for recent HIV seroconversion. Here is the <a href="http://www.thebody.com/Forums/AIDS/Meds/Current/Q169607.html" target=_new>link</a>.

I was assigned to the control group, so I'll take no meds, but will be closely monitored for 2 years (unless something changes where I need to take meds.) Hopefully things will turn out well.

My viral load is down to 9490 and my cd4 count is up to 786, so that's good.

Thanks again.

Response from Dr. Pierone

Hello and thanks for the follow up information. These are indeed very good numbers off therapy. Thanks for volunteering for this study perhaps it will help getting us closer to a better understanding of the risks and benefits of HAART for management of primary HIV infection. Best of luck!



Previous
Prickly skin after 2nd dose of new regimen
Next
Herpes meds effects on HIV

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement